Cargando…

8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma

BACKGROUND: Hypoxia plays a crucial role in immunotherapy of hepatocellular carcinoma (HCC) by changing the tumor microenvironment. Until now the association between hypoxia genes and prognosis of HCC remains obscure. We attempt to construct a hypoxia model to predict the prognosis in HCC. RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Congbo, Yang, Lei, Zhou, Kena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667367/
https://www.ncbi.nlm.nih.gov/pubmed/34895169
http://dx.doi.org/10.1186/s12876-021-02057-0
_version_ 1784614376269938688
author Cai, Congbo
Yang, Lei
Zhou, Kena
author_facet Cai, Congbo
Yang, Lei
Zhou, Kena
author_sort Cai, Congbo
collection PubMed
description BACKGROUND: Hypoxia plays a crucial role in immunotherapy of hepatocellular carcinoma (HCC) by changing the tumor microenvironment. Until now the association between hypoxia genes and prognosis of HCC remains obscure. We attempt to construct a hypoxia model to predict the prognosis in HCC. RESULTS: We screened out 3 hypoxia genes (ENO1, UGP2, TPI1) to make the model, which can predict prognosis in HCC. And this model emerges as an independent prognostic factor for HCC. A Nomogram was drawn to evaluate the overall survival in a more accurate way. Furthermore, immune infiltration state and immunosuppressive microenvironment of the tumor were detected in high-risk patients. CONCLUSION: We establish and validate a risk prognostic model developed by 3 hypoxia genes, which could effectively evaluate the prognosis of HCC patients. This prognostic model can be used as a guidance for hypoxia modification in HCC patients undergoing immunotherapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-021-02057-0.
format Online
Article
Text
id pubmed-8667367
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86673672021-12-13 8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma Cai, Congbo Yang, Lei Zhou, Kena BMC Gastroenterol Research BACKGROUND: Hypoxia plays a crucial role in immunotherapy of hepatocellular carcinoma (HCC) by changing the tumor microenvironment. Until now the association between hypoxia genes and prognosis of HCC remains obscure. We attempt to construct a hypoxia model to predict the prognosis in HCC. RESULTS: We screened out 3 hypoxia genes (ENO1, UGP2, TPI1) to make the model, which can predict prognosis in HCC. And this model emerges as an independent prognostic factor for HCC. A Nomogram was drawn to evaluate the overall survival in a more accurate way. Furthermore, immune infiltration state and immunosuppressive microenvironment of the tumor were detected in high-risk patients. CONCLUSION: We establish and validate a risk prognostic model developed by 3 hypoxia genes, which could effectively evaluate the prognosis of HCC patients. This prognostic model can be used as a guidance for hypoxia modification in HCC patients undergoing immunotherapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-021-02057-0. BioMed Central 2021-12-12 /pmc/articles/PMC8667367/ /pubmed/34895169 http://dx.doi.org/10.1186/s12876-021-02057-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cai, Congbo
Yang, Lei
Zhou, Kena
8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma
title 8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma
title_full 8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma
title_fullStr 8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma
title_full_unstemmed 8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma
title_short 8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma
title_sort 8destablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667367/
https://www.ncbi.nlm.nih.gov/pubmed/34895169
http://dx.doi.org/10.1186/s12876-021-02057-0
work_keys_str_mv AT caicongbo 8destablishmentandvalidationofahypoxiarelatedsignaturepredictingprognosisinhepatocellularcarcinoma
AT yanglei 8destablishmentandvalidationofahypoxiarelatedsignaturepredictingprognosisinhepatocellularcarcinoma
AT zhoukena 8destablishmentandvalidationofahypoxiarelatedsignaturepredictingprognosisinhepatocellularcarcinoma